搜尋
Milestone Pharmaceuticals Inc
MIST添加自選
0.801USD
-0.061-7.08%
交易中 09/24, 13:36（美東）
99.72M總市值
虧損本益比TTM
關於 Milestone Pharmaceuticals Inc 公司
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Milestone Pharmaceuticals Inc 簡介
公司代碼MIST
公司名稱Milestone Pharmaceuticals Inc
上市日期May 09, 2019
CEOOliveto (Joseph)
員工數量33
證券類型Ordinary Share
年結日May 09
公司地址420-1111 boul. Dr.-Frederik-Philips
城市MONTREAL
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Canada
郵編H4M 2X6
電話15143360444
網址https://www.milestonepharma.com
公司代碼MIST
上市日期May 09, 2019
CEOOliveto (Joseph)
Milestone Pharmaceuticals Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
常見問題
Milestone Pharmaceuticals Inc的前五大股東是誰？
Milestone Pharmaceuticals Inc的前五大股東如下：Dr. David Bharucha
有多少機構持有Milestone Pharmaceuticals Inc(MIST)的股份？
截至2026Q1，共有133家機構持有Milestone Pharmaceuticals Inc的股份，合計持有的股份價值約為30.89M，占公司總股份的25.86% 。與2025Q4相比，機構持股有所增加，增幅為-18702702.00。